June 5, 2007 — A patch designed to help damaged cardiac tissue recover from a heart attack has been successful in early animal testing and is moving toward potential human use, researchers report.

"It is a biodegradable, porous polyurethane scaffold that is placed atop the infarcted [damaged] region of the heart," explained study author William R. Wagner, a professor of surgery and bioengineering at the University of Pittsburgh. "It changes the environment during the remodeling process, and degrades over several months. The impact of it is to have a thicker heart wall."

June 4, 2007 — Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its AspirinWorks Test Kit, the Company's newest diagnostic product.

June 4, 2007 — Contrary to recent studies, proper use of a drug called aprotinin to reduce bleeding during heart surgery does not increase the risk of heart attack or stroke, according to a study in the June issue of The Journal of Thoracic and Cardiovascular Surgery.

June 4, 2007 — Biodegradable magnesium stents have been developed to treat blockages in coronary arteries. The stents will degrade within four months and achieve the same results as conventional stents, conclude authors of an article published in this week's edition of The Lancet.

June 4, 2007 — A new radiological test, used to detect acute coronary trauma has the ability to save valuable time and lives in trauma centers.

The contrast-enhanced 64-multi-detector computed tomography (MDCT) that reveals acute trauma to the aorta does not need confirmation from invasive catheter angiography, according to findings from the new Medical University of South Carolina study.

June 1, 2007 — Abbott announced it has completed its application to the U.S. Food and Drug Administration (FDA) to seek market approval for its XIENCE V Everolimus Eluting Coronary Stent System to treat coronary artery disease, with the submission of the final module of its Pre-Market Approval (PMA) application.

June 1, 2007 — Siemens recently announced the introduction of Syngo DynaCT Cardiac, which provides three-dimensional displays of the ventricle, even during an intervention.

June 1, 2007 —ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, was named one of America’s 100 Most Trustworthy Companies by Forbes.

Of the approximately 8,500 public companies reviewed to compile the list, ZOLL ranked 25th and was among only three Medical Equipment & Supplies companies listed.

June 1, 2007 — New findings show that the majority of people untrained in how to perform cardiopulmonary resuscitation, and even many trained emergency personnel, do not push with enough force to properly administer CPR.

The research tested 104 adults untrained in CPR and 83 firefighters trained in the procedure. Findings showed that most of the untrained people simply do not apply enough force, according to Leslie Geddes, Purdue University's Showalter Distinguished Professor Emeritus of Biomedical Engineering.

May 31 -- Cardiac Science Corp. announced today it has entered into a two-year marketing partnership with the City of Minneapolis, serving as the recommended provider of automated external defibrillators (AEDs) to participants in Minneapolis Project Heart Beat, the city's public access defibrillation (PAD) program. The agreement is renewable annually for three additional years.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now